Epigenetic enzyme mutations as mediators of anti-cancer drug resistance

表观遗传学 生物 染色质 癌症 抗药性 遗传学 组蛋白 突变 基因 癌症研究 生物信息学
作者
Sihong Chen,Yingxi Zhao,Shougeng Liu,Jiayu Zhang,Yehuda G. Assaraf,Wei Cui,Lihui Wang
出处
期刊:Drug Resistance Updates [Elsevier BV]
卷期号:61: 100821-100821 被引量:33
标识
DOI:10.1016/j.drup.2022.100821
摘要

Despite the rapid advancement in the introduction of new drugs for cancer therapy, the frequent emergence of drug resistance leads to disease progression or tumor recurrence resulting in dismal prognosis. Given that genetic mutations are thought to be important drivers of anti-cancer drug resistance, it is of paramount importance to pin-point mutant genes that mediate drug resistance and elucidate the underlying molecular mechanisms in order to develop novel modalities to surmount chemoresistance and achieve more efficacious and durable cancer therapies. Cumulative evidence suggests that epigenetic alterations, especially those mediated by epigenetic enzymes with high mutation rates in cancer patients, can be a crucial factor in the development of chemoresistance. Mutant epigenetic enzymes have altered enzymatic activity which may directly or indirectly affect the level of histone modifications. This can change chromatin structure and function hence altering the expression of target genes and eventually lead to chemoresistance. In the current review, we summarize epigenetic enzyme mutations and the consequent mechanisms of drug resistance in pre-clinical drug-resistance models and relapsed cancer patient specimens. We also introduce previously unreported mutation sites in the DOT1 domain of DOT1L, which are related to lung cancer drug resistance. It is worth noting that mutations occur not only in domains with enzymatic activity but also in non-catalytic regions. Each protein domain is an evolutionarily conserved region with independent functional properties. This may provide a rationale for the potential development of small molecule inhibitors which target various functional domains of epigenetic enzymes. Finally, based on the multitude of mechanisms of drug resistance, we propose several therapeutic strategies to reverse or overcome drug-resistance phenotypes, with the aim to provide cancer patients with novel efficacious combination therapeutic regimens and strategies to improve patient prognosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
项听蓉完成签到,获得积分10
刚刚
hao完成签到,获得积分10
刚刚
不安的白昼完成签到 ,获得积分10
1秒前
不知道完成签到,获得积分10
3秒前
3秒前
chebo发布了新的文献求助10
4秒前
一一一应助滕皓轩采纳,获得10
4秒前
一一一应助滕皓轩采纳,获得10
4秒前
科研通AI2S应助滕皓轩采纳,获得10
4秒前
大个应助十曰采纳,获得10
5秒前
li完成签到 ,获得积分10
6秒前
尘埃之影完成签到,获得积分10
8秒前
陶醉的钢笔完成签到 ,获得积分10
9秒前
飞行的子弹完成签到,获得积分20
10秒前
泥花完成签到,获得积分10
10秒前
10秒前
mr_beard完成签到 ,获得积分10
11秒前
岑晓冰完成签到 ,获得积分10
13秒前
啦啦啦完成签到,获得积分10
13秒前
感动的小鸽子完成签到 ,获得积分10
14秒前
lxj完成签到 ,获得积分10
14秒前
无辜的蜗牛完成签到 ,获得积分10
14秒前
xiaojin完成签到,获得积分10
15秒前
程程完成签到,获得积分10
15秒前
duckspy发布了新的文献求助30
15秒前
15秒前
sunyanghu369发布了新的文献求助30
20秒前
hdc12138完成签到,获得积分10
21秒前
飞龙在天完成签到,获得积分0
21秒前
狄淇儿完成签到 ,获得积分10
21秒前
吨吨完成签到,获得积分10
22秒前
小芒果完成签到,获得积分0
26秒前
27秒前
杰克李李完成签到,获得积分10
28秒前
pakiorder完成签到,获得积分20
30秒前
无心的雅霜完成签到,获得积分10
30秒前
1122完成签到,获得积分10
31秒前
王磊完成签到,获得积分10
31秒前
顺心醉蝶完成签到 ,获得积分10
31秒前
量子星尘发布了新的文献求助10
31秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038235
求助须知:如何正确求助?哪些是违规求助? 3575992
关于积分的说明 11374009
捐赠科研通 3305760
什么是DOI,文献DOI怎么找? 1819276
邀请新用户注册赠送积分活动 892662
科研通“疑难数据库(出版商)”最低求助积分说明 815022